{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T07:41:39Z","timestamp":1759736499000,"version":"build-2065373602"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100009610","name":"Pontificia Universidad Cat\u00f3lica de Chile","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009610","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.prp.2023.154776","type":"journal-article","created":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T19:50:48Z","timestamp":1692820248000},"page":"154776","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["PRAME\/MELAN-A double immunostaining as a diagnostic tool for conjunctival melanocytic lesions: A South American experience"],"prefix":"10.1016","volume":"250","author":[{"given":"Pedro","family":"Carvajal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3164-1842","authenticated-orcid":false,"given":"Pablo","family":"Zoroquiain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2023.154776_bib1","first-page":"15","article-title":"Melanocytic conjunctival tumors","volume":"vol. 18","author":"Kurli","year":"2005"},{"issue":"4","key":"10.1016\/j.prp.2023.154776_bib2","first-page":"577","article-title":"Prognostic factors and survival for malignant conjunctival melanoma and squamous cell carcinoma over four decades","volume":"vol. 40","author":"Abt","year":"2019","journal-title":"Am. J. Otolaryngol. Head. Neck Med. Surg."},{"issue":"4","key":"10.1016\/j.prp.2023.154776_bib3","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S0161-6420(89)32878-8","article-title":"Benign conjunctival melanocytic lesions","volume":"vol. 96","author":"Folberg","year":"1989","journal-title":"Ophthalmology"},{"key":"10.1016\/j.prp.2023.154776_bib4","first-page":"142","article-title":"Conjunctival melanoma and melanocytic intra-epithelial neoplasia","author":"Kenawy","year":"2013","journal-title":"Eye (Basingstoke), Nat. Publ. Group"},{"issue":"1","key":"10.1016\/j.prp.2023.154776_bib5","doi-asserted-by":"crossref","DOI":"10.4321\/S0365-66912009000100003","article-title":"Tumores de la conjuntiva","volume":"vol. 84","author":"Saornil","year":"2009","journal-title":"Arch. Soc. Esp. Oftalmol."},{"key":"10.1016\/j.prp.2023.154776_bib6","article-title":"World Health Organization classification of tumours","volume":"Volume 12","author":"Grossniklaus","year":"2018"},{"key":"10.1016\/j.prp.2023.154776_bib7","first-page":"109","article-title":"Conjunctival tumors: Review of clinical features, risks, biomarkers, and outcomes - The 2017 J. Donald M. Gass Lecture","volume":"vol. 6","author":"Shields","year":"2017"},{"issue":"6","key":"10.1016\/j.prp.2023.154776_bib8","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1001\/jamaophthalmol.2020.0531","article-title":"Incidence and survival of patients with conjunctival Melanoma in Europe","volume":"vol. 138","author":"Virgili","year":"2020","journal-title":"JAMA Ophthalmol."},{"issue":"3","key":"10.1016\/j.prp.2023.154776_bib9","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1177\/1066896911435697","article-title":"P16ink4a expression in benign and malignant melanocytic conjunctival lesions","volume":"vol. 20","author":"Zoroquiain","year":"2012","journal-title":"Int J. Surg. Pathol."},{"issue":"9","key":"10.1016\/j.prp.2023.154776_bib10","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/j.ophtha.2004.02.013","article-title":"Clinical survey of 1643 melanocytic and nonmelanocytic conjunctival tumors","volume":"vol. 111","author":"Shields","year":"2004","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.prp.2023.154776_bib11","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S1074-7613(00)80426-4","article-title":"Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor","volume":"vol. 6","author":"Ikeda","year":"1997","journal-title":"Immunity"},{"key":"10.1016\/j.prp.2023.154776_bib12","article-title":"Cancer testis antigens and immunotherapy: Where do we stand in the targeting of PRAME?","volume":"vol. 11","author":"Al-Khadairi","year":"2019"},{"issue":"2","key":"10.1016\/j.prp.2023.154776_bib13","first-page":"195","article-title":"RAPID COMMUNICATION monoclonal antibodies specific for melanocytic tumors distinguish subpopulations of melanocytes","volume":"vol. 123","author":"Gown","year":"1986","journal-title":"Am. J. Pathol."},{"issue":"4","key":"10.1016\/j.prp.2023.154776_bib14","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/PAS.0000000000001393","article-title":"Immunohistochemistry for PRAME in the distinction of nodal nevi from metastatic melanoma","volume":"vol. 44","author":"Lezcano","year":"2020","journal-title":"Am. J. Surg. Pathol."},{"issue":"2","key":"10.1016\/j.prp.2023.154776_bib15","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1001\/archophthalmol.2009.394","article-title":"Immunohistochemical studies of conjunctival nevi and melanomas","volume":"vol. 128","author":"Jakobiec","year":"2010","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.prp.2023.154776_bib16","doi-asserted-by":"crossref","unstructured":"C. Lezcano, A.A. Jungbluth, K.J. Busam, Comparison of Immunohistochemistry for PRAME With Cytogenetic Test Results in the Evaluation of Challenging Melanocytic Tumors, 2020. [Online]. Available: \u3008www.ajsp.com\u3009.","DOI":"10.1097\/PAS.0000000000001492"},{"issue":"10","key":"10.1016\/j.prp.2023.154776_bib17","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1136\/bjo.2009.167445","article-title":"Expression of MCSP and PRAME in conjunctival melanoma","volume":"vol. 94","author":"Westekemper","year":"2010","journal-title":"Br. J. Ophthalmol."},{"issue":"11","key":"10.1016\/j.prp.2023.154776_bib18","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1097\/PAS.0000000000001134","article-title":"PRAME expression in melanocytic tumors","volume":"vol. 42","author":"Lezcano","year":"2018","journal-title":"Am. J. Surg. Pathol."},{"issue":"9","key":"10.1016\/j.prp.2023.154776_bib19","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1111\/cup.14000","article-title":"The utility of PRAME immunohistochemistry in the evaluation of challenging melanocytic tumors","volume":"vol. 48","author":"Alomari","year":"2021","journal-title":"J. Cutan. Pathol."},{"issue":"7","key":"10.1016\/j.prp.2023.154776_bib20","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1111\/cup.13958","article-title":"The utility of PRAME staining in identifying malignant transformation of melanocytic nevi","volume":"vol. 48","author":"Lohman","year":"2021","journal-title":"J. Cutan. Pathol."},{"key":"10.1016\/j.prp.2023.154776_bib21","doi-asserted-by":"crossref","unstructured":"M. Grillini, C. Ricci, V. Pino, S. Pedrini, M. Fiorentino, and B. Corti, HMB45\/PRAME, a Novel Double Staining for the Diagnosis of Melanocytic Neoplasms: Technical Aspects, Results, and Comparison With Other Commercially Available Staining (PRAME and Melan A\/PRAME), 2021. doi: 10.1097\/PAI.0000000000000972.","DOI":"10.1097\/PAI.0000000000000972"},{"issue":"5","key":"10.1016\/j.prp.2023.154776_bib22","doi-asserted-by":"crossref","first-page":"632","DOI":"10.5858\/arpa.2021-0006-RA","article-title":"Conjunctival melanocytic lesions","volume":"vol. 146","author":"Bresler","year":"2022","journal-title":"Arch. Pathol. Lab Med"},{"issue":"2","key":"10.1016\/j.prp.2023.154776_bib23","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.yexmp.2017.01.016","article-title":"Immunohistochemical profiling including beta-catenin in conjunctival melanocytic lesions","volume":"vol. 102","author":"Reddy","year":"2017","journal-title":"Exp. Mol. Pathol."},{"issue":"12","key":"10.1016\/j.prp.2023.154776_bib24","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1111\/cup.14078","article-title":"PRAME immunohistochemistry is useful in the evaluation of conjunctival melanomas, nevi, and primary acquired melanosis","volume":"vol. 48","author":"LeBlanc","year":"2021","journal-title":"J. Cutan. Pathol."},{"issue":"6","key":"10.1016\/j.prp.2023.154776_bib25","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1111\/his.14452","article-title":"PRAME expression in melanocytic lesions of the conjunctiva","volume":"vol. 79","author":"\u0160ekoranja","year":"2021","journal-title":"Histopathology"},{"key":"10.1016\/j.prp.2023.154776_bib26","doi-asserted-by":"crossref","unstructured":"D. de Carvalho, B. Mello, W. Pereira, G. Amarante-Mendes, \u201cPRAME\/EZH2-Mediated Regulation of TRAIL: A New Target for Cancer Therapy,\u201d 2013.","DOI":"10.2174\/156652413804810727"},{"issue":"22","key":"10.1016\/j.prp.2023.154776_bib27","doi-asserted-by":"crossref","first-page":"10376","DOI":"10.1111\/jcmm.16967","article-title":"Cancer testis antigen PRAME: an anti\u2010cancer target with immunomodulatory potential","volume":"vol. 25","author":"Naik","year":"2021","journal-title":"J. Cell Mol. Med"},{"issue":"1","key":"10.1016\/j.prp.2023.154776_bib28","doi-asserted-by":"crossref","DOI":"10.1186\/s13569-017-0077-3","article-title":"Overexpressed PRAME is a potential immunotherapy target in sarcoma subtypes","volume":"vol. 7","author":"Roszik","year":"2017","journal-title":"Clin. Sarcoma Res"},{"issue":"3","key":"10.1016\/j.prp.2023.154776_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajo.2007.10.022","article-title":"Population-based incidence of conjunctival melanoma in various races and ethnic groups and comparison with other melanomas","volume":"vol. 145","author":"Hu","year":"2008","journal-title":"Am. J. Ophthalmol."},{"issue":"6","key":"10.1016\/j.prp.2023.154776_bib30","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1111\/j.1751-1097.2006.tb09821.x","article-title":"Latitude and incidence of ocular melanoma","volume":"vol. 82","author":"Yu","year":"2006","journal-title":"Photochem. Photobio."},{"issue":"3","key":"10.1016\/j.prp.2023.154776_bib31","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.jaad.2020.03.094","article-title":"Racial differences in time to treatment for melanoma","volume":"vol. 83","author":"Tripathi","year":"2020","journal-title":"J. Am. Acad. Dermatol."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033823004764?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033823004764?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T07:02:11Z","timestamp":1759734131000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033823004764"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":31,"alternative-id":["S0344033823004764"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2023.154776","relation":{},"ISSN":["0344-0338"],"issn-type":[{"type":"print","value":"0344-0338"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PRAME\/MELAN-A double immunostaining as a diagnostic tool for conjunctival melanocytic lesions: A South American experience","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2023.154776","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"154776"}}